The role of neuroinflammation and neurovascular dysfunction in major depressive disorder

Sang Won Jeon, Yong Ku Kim

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Although depression has generally been explained with monoamine theory, it is far more multifactorial, and therapies that address the disease’s pathway have not been developed. In this context, an understanding of neuroinflammation and neurovascular dysfunction would enable a more comprehensive approach to depression. Inflammation is in a sense a type of allostatic load involving the immune, endocrine, and nervous systems. Neuroinflammation is involved in the pathophysiology of depression by increasing proinflammatory cytokines, activating the hypothalamus–pituitary–adrenal axis, increasing glucocorticoid resistance, and affecting serotonin synthesis and metabolism, neuronal apoptosis and neurogenesis, and neuroplasticity. In future, identifying the subtypes of depression with increased vulnerability to inflammation and testing the effects of inflammatory modulating agents in these patient groups through clinical trials will lead to more concrete conclusions on the matter. The vascular depression hypothesis is supported by evidence for the association between vascular disease and late-onset depression and between ischemic brain lesions and distinctive depressive symptoms. Vascular depression may be the entity most suitable for studies of the mechanisms of depression. Pharmacotherapies used in the prevention and treatment of cerebrovascular disease may help prevent vascular depression. In future, developments in structural and functional imaging, electrophysiology, chronobiology, and genetics will reveal the association between depression and brain lesions. This article aims to give a general review of the existing issues examined in the literature pertaining to depression-related neuroinflammatory and vascular functions, related pathophysiology, applicability to depression treatment, and directions for future research.

Original languageEnglish
Pages (from-to)179-192
Number of pages14
JournalJournal of Inflammation Research
Volume11
DOIs
Publication statusPublished - 2018 May 8

Fingerprint

Major Depressive Disorder
Depression
Blood Vessels
Allostasis
Inflammation
Cerebrovascular Disorders
Neuronal Plasticity
Endocrine System
Electrophysiology
Neurogenesis
Brain
Proxy
Vascular Diseases
Nervous System
Immune System
Serotonin
Therapeutics
Clinical Trials

Keywords

  • Depressive disorder
  • Neuroinflammation
  • Psychoneuroimmunology
  • Vascular depression
  • Vascular disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. / Jeon, Sang Won; Kim, Yong Ku.

In: Journal of Inflammation Research, Vol. 11, 08.05.2018, p. 179-192.

Research output: Contribution to journalReview article

@article{c0885fffef054b0eae63d78226ea343c,
title = "The role of neuroinflammation and neurovascular dysfunction in major depressive disorder",
abstract = "Although depression has generally been explained with monoamine theory, it is far more multifactorial, and therapies that address the disease’s pathway have not been developed. In this context, an understanding of neuroinflammation and neurovascular dysfunction would enable a more comprehensive approach to depression. Inflammation is in a sense a type of allostatic load involving the immune, endocrine, and nervous systems. Neuroinflammation is involved in the pathophysiology of depression by increasing proinflammatory cytokines, activating the hypothalamus–pituitary–adrenal axis, increasing glucocorticoid resistance, and affecting serotonin synthesis and metabolism, neuronal apoptosis and neurogenesis, and neuroplasticity. In future, identifying the subtypes of depression with increased vulnerability to inflammation and testing the effects of inflammatory modulating agents in these patient groups through clinical trials will lead to more concrete conclusions on the matter. The vascular depression hypothesis is supported by evidence for the association between vascular disease and late-onset depression and between ischemic brain lesions and distinctive depressive symptoms. Vascular depression may be the entity most suitable for studies of the mechanisms of depression. Pharmacotherapies used in the prevention and treatment of cerebrovascular disease may help prevent vascular depression. In future, developments in structural and functional imaging, electrophysiology, chronobiology, and genetics will reveal the association between depression and brain lesions. This article aims to give a general review of the existing issues examined in the literature pertaining to depression-related neuroinflammatory and vascular functions, related pathophysiology, applicability to depression treatment, and directions for future research.",
keywords = "Depressive disorder, Neuroinflammation, Psychoneuroimmunology, Vascular depression, Vascular disease",
author = "Jeon, {Sang Won} and Kim, {Yong Ku}",
year = "2018",
month = "5",
day = "8",
doi = "10.2147/JIR.S141033",
language = "English",
volume = "11",
pages = "179--192",
journal = "Journal of Inflammation Research",
issn = "1178-7031",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - The role of neuroinflammation and neurovascular dysfunction in major depressive disorder

AU - Jeon, Sang Won

AU - Kim, Yong Ku

PY - 2018/5/8

Y1 - 2018/5/8

N2 - Although depression has generally been explained with monoamine theory, it is far more multifactorial, and therapies that address the disease’s pathway have not been developed. In this context, an understanding of neuroinflammation and neurovascular dysfunction would enable a more comprehensive approach to depression. Inflammation is in a sense a type of allostatic load involving the immune, endocrine, and nervous systems. Neuroinflammation is involved in the pathophysiology of depression by increasing proinflammatory cytokines, activating the hypothalamus–pituitary–adrenal axis, increasing glucocorticoid resistance, and affecting serotonin synthesis and metabolism, neuronal apoptosis and neurogenesis, and neuroplasticity. In future, identifying the subtypes of depression with increased vulnerability to inflammation and testing the effects of inflammatory modulating agents in these patient groups through clinical trials will lead to more concrete conclusions on the matter. The vascular depression hypothesis is supported by evidence for the association between vascular disease and late-onset depression and between ischemic brain lesions and distinctive depressive symptoms. Vascular depression may be the entity most suitable for studies of the mechanisms of depression. Pharmacotherapies used in the prevention and treatment of cerebrovascular disease may help prevent vascular depression. In future, developments in structural and functional imaging, electrophysiology, chronobiology, and genetics will reveal the association between depression and brain lesions. This article aims to give a general review of the existing issues examined in the literature pertaining to depression-related neuroinflammatory and vascular functions, related pathophysiology, applicability to depression treatment, and directions for future research.

AB - Although depression has generally been explained with monoamine theory, it is far more multifactorial, and therapies that address the disease’s pathway have not been developed. In this context, an understanding of neuroinflammation and neurovascular dysfunction would enable a more comprehensive approach to depression. Inflammation is in a sense a type of allostatic load involving the immune, endocrine, and nervous systems. Neuroinflammation is involved in the pathophysiology of depression by increasing proinflammatory cytokines, activating the hypothalamus–pituitary–adrenal axis, increasing glucocorticoid resistance, and affecting serotonin synthesis and metabolism, neuronal apoptosis and neurogenesis, and neuroplasticity. In future, identifying the subtypes of depression with increased vulnerability to inflammation and testing the effects of inflammatory modulating agents in these patient groups through clinical trials will lead to more concrete conclusions on the matter. The vascular depression hypothesis is supported by evidence for the association between vascular disease and late-onset depression and between ischemic brain lesions and distinctive depressive symptoms. Vascular depression may be the entity most suitable for studies of the mechanisms of depression. Pharmacotherapies used in the prevention and treatment of cerebrovascular disease may help prevent vascular depression. In future, developments in structural and functional imaging, electrophysiology, chronobiology, and genetics will reveal the association between depression and brain lesions. This article aims to give a general review of the existing issues examined in the literature pertaining to depression-related neuroinflammatory and vascular functions, related pathophysiology, applicability to depression treatment, and directions for future research.

KW - Depressive disorder

KW - Neuroinflammation

KW - Psychoneuroimmunology

KW - Vascular depression

KW - Vascular disease

UR - http://www.scopus.com/inward/record.url?scp=85047113433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047113433&partnerID=8YFLogxK

U2 - 10.2147/JIR.S141033

DO - 10.2147/JIR.S141033

M3 - Review article

AN - SCOPUS:85047113433

VL - 11

SP - 179

EP - 192

JO - Journal of Inflammation Research

JF - Journal of Inflammation Research

SN - 1178-7031

ER -